8847
-
Drug Design, Development and Therapy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Drug Design, Development and Therapy
(663,818) Views
Editor in Chief Daniel S Pilch, PhD
1177-8881
ReviewRequirements for acquiring a high-quality house dust mite extract for allergen immunotherapy
Video available for this paperFrati F, Incorvaia C, David M, Scurati S, Seta S, Padua G, Cattaneo E, Cavaliere C, Di Rienzo A, Dell'Albani I, Puccinelli P
Drug Design, Development and Therapy 2012, 6:117-123
18 May 2012
Review
Update on the development of lurasidone as a treatment for patients with acute schizophrenia
Yasui-Furukori N
Drug Design, Development and Therapy 2012, 6:107-115
08 May 2012
Review
Imiglucerase in the treatment of Gaucher disease: a history and perspective
Deegan PB, Cox TM
Drug Design, Development and Therapy 2012, 6:81-106
18 April 2012
Original Research
A first-in-man study to evaluate the safety, tolerability, and pharmacokinetics of pasireotide (SOM230), a multireceptor-targeted somatostatin analog, in healthy volunteers
Golor G, Hu K, Ruffin M, Buchelt A, Bouillaud E, Wang Y, Maldonado M
Drug Design, Development and Therapy 2012, 6:71-79
19 April 2012
Original Research
Stability and microbiological properties of a new formulation of epoprostenol sodium when reconstituted and diluted
Lambert O, Bandilla D, Iyer R, Witchey-Lakshmanan L, Palepu N
Drug Design, Development and Therapy 2012, 6:61-70
28 March 2012
Methodology
Why (not) go east? Comparison of findings from FDA Investigational New Drug study site inspections performed in Central and Eastern Europe with results from the USA, Western Europe, and other parts of the world
Caldron PH, Gavrilova SI, Kropf S
Drug Design, Development and Therapy 2012, 6:53-60
27 March 2012
Original Research
Pharmacokinetics of iron isomaltoside 1000 in patients with inflammatory bowel disease
Nordfjeld K, Andreasen H, Thomsen LL
Drug Design, Development and Therapy 2012, 6:43-51
05 March 2012
Original Research
Solubilization of beclomethasone dipropionate in sterically stabilized phospholipid nanomicelles (SSMs): physicochemical and in vitro evaluations
Sahib MN, Abdulameer SA, Darwis Y, Peh KK, Tan YT
Drug Design, Development and Therapy 2012, 6:29-42
17 February 2012
Review
Inhaled treprostinil: a therapeutic review
Channick RN, Voswinckel R, Rubin LJ
Drug Design, Development and Therapy 2012, 6:19-28
24 January 2012
Review
Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer
Rehman Y, Rosenberg JE
Drug Design, Development and Therapy 2012, 6:13-18
16 January 2012
Review
Treatment for primary hypothyroidism: current approaches and future possibilities
Chakera AJ, Pearce SHS, Vaidya B
Drug Design, Development and Therapy 2012, 6:1-11
22 December 2011
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
